Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with Pegylated interferon alfa-2a and ribavirin

by Fabri Milotka, Ružić Maja, Lendak Dajana, Preveden Tomislav, Fabri Izabela, Petrić Vedrana
Published 2013-01-01

Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users

by Ružić Maja, Fabri Milotka, Klašnja Biljana, Pobor Marta, Švarc Daniela, Jovelić Aleksandra, Fabri Izabela
Published 2010-01-01